Trials / Completed
CompletedNCT06245421
Evaluation of the Efficacy and Safety of DM934 Versus Théalose on Eye Dryness
Multicentric, Randomized, Comparative Clinical Study on the Evaluation of the Efficacy and Safety of DM934 Versus Théalose on the Treatment of Moderate to Severe Ocular Dryness
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 85 (actual)
- Sponsor
- Horus Pharma · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is a multicentric, comparative, randomized, investigator-blinded, parallel group study to demonstrate the non-inferiority of DM934 in comparison with Théalose in terms of cornea and conjunctiva staining (Oxford score) on patients with moderate to severe ocular dryness, after 35 days of treatment
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | DM934 | 1 drop in each eye, 4 to 6 times per day |
| DEVICE | Théalose | 1 drop in each eye, 4 to 6 times per day |
Timeline
- Start date
- 2024-03-07
- Primary completion
- 2024-08-12
- Completion
- 2024-09-30
- First posted
- 2024-02-07
- Last updated
- 2025-02-13
Locations
5 sites across 4 countries: France, Poland, Spain, United Kingdom
Source: ClinicalTrials.gov record NCT06245421. Inclusion in this directory is not an endorsement.